𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis

✍ Scribed by R. LOOMBA; G. LUTCHMAN; D. E. KLEINER; M. RICKS; J. J. FELD; B. B. BORG; A. MODI; P. NAGABHYRU; A. E. SUMNER; T. J. LIANG; J. H. HOOFNAGLE

Book ID
108605495
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
238 KB
Volume
29
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Metformin in the treatment of patients w
Metformin in the treatment of patients with non-alcoholic steatohepatitis
✍ A. Uygun; A. Kadayifci; A. T. Isik; T. Ozgurtas; S. Deveci; A. Tuzun; Z. Yesilov πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 77 KB

## Summary **Background** : Increased insulin resistance is the major pathogenic mechanism in the development of non‐alcoholic steatohepatitis. **Aim** : To investigate the therapeutic effect of metformin, a well‐known insulin‐sensitizing agent, in the treatment of non‐alcoholic steatohepatitis.

Ursodeoxycholic acid or clofibrate in th
Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: A pilot study
✍ J Laurin; K D Lindor; J S Crippin; A Gossard; G J Gores; J Ludwig; J Rakela; D B πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 154 KB πŸ‘ 1 views

Non-alcohol-induced steatohepatitis (NASH) is characterized by elevated serum aminotransferase activities with hepatic steatosis, inflammation, and occasionally fibrosis that may progress to cirrhosis. No established treatment exists for this potentially serious disorder. Our aim was to conduct a pi